Chitinase-3-like-1 protein accelerates cancer progression by suppressing the immune response (IMAGE)
Caption
These findings pave the way for the development of commercial antibodies that could supplement chemotherapy.
Credit
National Cheng Kung University, Taiwan
Usage Restrictions
You are free to share and adapt the material. Attribution is required.
License
Original content